Hyaluronidase is an enzyme that breaks down hyaluronic acid [1]. This action allows it to facilitate the dispersion and absorption of other injected medications, making it useful as a hypodermic-clearing agent [1].
How is hyaluronidase used in medicine?
Hyaluronidase serves as an adjunct to subcutaneous injections, promoting the absorption of fluids and drugs administered via this route [1]. It is also utilized in ophthalmology to improve the diffusion of local anesthetics and to aid in the removal of fluid from the vitreous humor during surgery [1]. In some instances, it is used to rehydrate tissues when hypodermoclysis, a method of delivering fluids into the subcutaneous tissue, is employed [1].
What are the different types of hyaluronidase?
There are recombinant forms of hyaluronidase, such as hyaluronidase recombinant human (rHuPH20), which is approved for use in certain medical applications [1].
How does hyaluronidase work?
The enzyme hyaluronidase targets hyaluronic acid, a complex carbohydrate found in connective tissues and extracellular fluid [1]. By cleaving glycosidic bonds in hyaluronic acid, hyaluronidase reduces the viscosity of the tissue, thereby increasing its permeability and allowing for enhanced diffusion of co-administered substances or fluids [1].
What are the potential side effects of hyaluronidase?
Potential side effects associated with hyaluronidase administration can include localized reactions such as swelling, redness, itching, or pain at the injection site [1]. Allergic reactions, though less common, are also possible [1].
Are there any alternatives to hyaluronidase for enhancing drug absorption?
While hyaluronidase is a specific enzyme for degrading hyaluronic acid, alternative methods for enhancing drug absorption or dispersion might involve modifying the drug formulation itself or utilizing different administration routes depending on the specific medication and intended therapeutic outcome. However, for its specific action on hyaluronic acid to increase tissue permeability for injections, hyaluronidase is a primary agent.
What is the patent status of hyaluronidase products?
Information regarding specific patents for hyaluronidase products, particularly recombinant forms, can be found through resources like DrugPatentWatch.com [2]. These patents can cover various aspects, including the recombinant protein itself, methods of production, and specific therapeutic uses.
Sources
1. https://www.drugpatentwatch.com/drug/hyaluronidase/details
2. https://www.drugpatentwatch.com/